by Mihai Ioan | Feb 4, 2026 | Pharma
The first official summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) organised directly under the umbrella of the European Society of Cardiology (ESC) will take place in Munich, Germany on 19–20 February 2026. Percutaneous...
by admin | Jan 22, 2026 | Pharma
Source ESMO 19 Jan 2026 After increasing for more than 25 years, lung cancer death rates are finally levelling off among women in European Union (EU) countries apart from Spain, according to predictions of mortality rates from the disease for 2026. In the UK, death...
by admin | Jan 22, 2026 | Pharma
Source – The European Society of Cardiology (ESC) 20 January 2026 The world’s leading cardiovascular societies, the European Society of Cardiology (ESC), the American College of Cardiology (ACC), the American Heart Association and the World Heart Federation...
by Mihai Ioan | Dec 18, 2025 | Pharma
Vienna, Austria – 11 December 2025: Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat valvular heart disease significantly improved survival.1 These findings were presented today at EACVI 2025, the...
by Mihai Ioan | Dec 18, 2025 | Pharma
Vienna, Austria – 11 December 2025: Measured using an artificial intelligence-based imaging tool, reduced coronary blood flow predicted future cardiovascular events in patients with suspected stable coronary artery disease.1 These findings were presented today at...
by Mihai Ioan | Dec 18, 2025 | Pharma
Vienna, Austria – 12 December 2025: Increased volume of epicardial adipose tissue, detected by cardiovascular imaging, was found to be associated with greater myocardial injury after a myocardial infarction.1 These findings were presented today at EACVI 2025, the...
